Santero Therapeutics
santero.be
Actively hiring
Rare Disease Therapeutics
Biotechnology
Health Care
Follow
Overview
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Backers
1
Newton Biocapital
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
2021
Founded
Backed byfrom the funds' portfolios and accelerator catalogs
Newton Biocapital Investors in similar startupsfunds that back the companies most like this one
backs Mendra window
backs Oak Hill Bio
Similar startupsby what they do, their industry and backers
Overview. Ambros Therapeutics, headquartered in San Diego, California, is a clinical-stage biotechnology company focused on the development…
About Us NephroDI Therapeutics is developing a novel AMPK activator as a first-in-class potential therapy for Nephrogenic Diabetes…
Oak Hill Bio is a clinical-stage biotechnology company focused on acquiring and developing outstanding rare disease drugs that have been…
AdipoPharma. We are developing PATAS, a unique first-in-class insulin sensitizer that targets the adipocyte and that will treat insulin…
Human cells cannot degrade cholesterol, leading to several chronic and orphan diseases. Repair Biotechnologies’ Cholesterol Degrading…
US FDA Grants Orphan Drug and Rare Pediatric Disease Designations to GEn1E Lifesciences' Dual Signal Modulator for the Treatment of…
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Charleroi
Belgium
HQ
Copyright © 2026 - Santero therapeutics
10 rue Clément Ader6041 Charleroi